You are on page 1of 2

NAME: LESMORAS, JUDY ICELEY H.

YEAR & COURSE: BSN 3-B DATE: MARCH 10, 2024

DRUG MECHANISM OF INDICATION CONTRAINDICATION ADVERSE EFFECT OF THE NURSING INTERVENTION AND
STUDY ACTION DRUG PRECAUTION

Generic Works by inhibiting the used for the  Hypersensiti  Diarrhea  Take the
Name: mucopeptide synthesis treatment of the vity to medication exactly
Ceftriaxone in the bacterial cell infections cephalospori  Hypersensitivity as prescribed and
wall. The beta-lactam (respiratory, skin, ns or reactions (e.g., complete the full
moiety of ceftriaxone soft tissue, UTI, penicillin rash, itching, course of
Brand binds to ENT) caused by anaphylaxis) treatment, even if
Names: carboxypeptidases, susceptible  History of feeling better.
Rocephin endopeptidases, and organisms. severe  Clostridium
transpeptidases in the allergic difficile-associated  Report any signs of
bacterial cytoplasmic reactions to diarrhea allergic reactions
Dosage: membrane. These beta-lactam (e.g., rash, itching,
1 gram enzymes are involved antibiotics  Nausea and difficulty
in cell-wall synthesis vomiting breathing)
and cell division.  Neonates immediately to a
Route: Binding of ceftriaxone with  Headache healthcare
Intravenous to these enzymes hyperbilirubi provider.
causes the enzyme to nemia  Injection site
lose activity; therefore, reactions (pain,  Inform the
Frequency: the bacteria produce swelling) healthcare provider
Once daily defective cell walls, of any history of
causing cell death allergies,
 Increased risk of
superinfections particularly to
cephalosporins or
 Elevated liver penicillin.
enzymes

 Hematologic
abnormalities (e.g.,
leukopenia,
thrombocytopenia)
NAME: LESMORAS, JUDY ICELEY H. YEAR & COURSE: BSN 3-B DATE: MARCH 10, 2024

You might also like